Researchers: Breast cancer drug could help more patients

This undated photo provided by Daiichi Sankyo and AstraZeneca in June 2022 shows a vial and packaging for their Enhertu, an antibody-chemotherapy drug administered intravenously.

Until now, breast cancers have been categorized as either HER2-positive — the cancer cells have more of the protein than normal — or HER2-negative. Doctors reporting the advance Sunday said it will make “HER2-low” a new category for guiding breast cancer treatment. In the new study, the drug lengthened the time patients lived without their cancer progressing and improved survival compared with patients given standard chemotherapy.

What cancer

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Drug could help thousands with advanced breast cancer, researchers sayThe latest gain for targeted cancer therapy could open new treatment possibilities to thousands of patients with advanced breast cancer. 🙏
Source: FOX29philly - 🏆 570. / 51 Read more »

Researchers: Breast cancer drug could help more patientsDoctors are reporting a new gain in breast cancer treatment.
Source: ksatnews - 🏆 442. / 53 Read more »

Drug could help thousands with advanced breast cancer, researchers sayThe latest gain for targeted cancer therapy could open new treatment possibilities to thousands of patients with advanced breast cancer. Dude. Breast cancer is clobbered. Maybe could we get a scientist somewhere to spend a minute on gastro cancers that we are all going to die from because of years of unadulterated toxins in our foods.
Source: fox32news - 🏆 547. / 51 Read more »

Researchers: Breast Cancer Drug Could Help More PatientsDoctors are reporting a new gain in breast cancer treatment. Some HER2 negative breast cancers are actually “HER2 low” and can benefit from a drug targeting the HER2 protein.
Source: nbcsandiego - 🏆 524. / 51 Read more »